𝔖 Bobbio Scriptorium

✦ LIBER ✦

Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?

✍ Scribed by Kim K. Adkison; David G. Barrett; David N. Deaton; Robert T. Gampe; Anne M. Hassell; Stacey T. Long; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; J. Alan Payne; Lisa M. Shewchuk; Kevin J. Wells-Knecht; Derril H. Willard Jr.; Lois L. Wright

Book ID: 108073862
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 171 KB
Volume: 16
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2005.10.108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Semicarbazone-Based Inhibitors of Cathep

Semicarbazone-Based Inhibitors of Cathepsin K, Are They Prodrugs for Aldehyde Inhibitors?

✍ David N. Deaton; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 17 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Peptide Aldehyde Inhibitors of Cathepsin

Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo

✍ Bartholomew J. Votta; Mark A. Levy; Alison Badger; Jeremy Bradbeer; Robert A. Do 📂 Article 📅 1997 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 666 KB

Use of Papain as a Model for the Structu

Use of Papain as a Model for the Structure-Based Design of Cathepsin K Inhibitors: Crystal Structures of Two Papain−Inhibitor Complexes Demonstrate Binding to S‘-Subsites

✍ LaLonde, Judith M.; Zhao, Baoguang; Smith, Ward W.; Janson, Cheryl A.; DesJarlai 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 196 KB

Pharmaceutical Benefits Scheme criteria

Pharmaceutical Benefits Scheme criteria for the use of tumour necrosis factor-α inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?

✍ M. D. Smith; M. J. Ahern 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB